BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20427388)

  • 21. [Aspirin in the prevention of colorectal cancer].
    Zubiaurre L; Bujanda Fernández de Pierola L
    Gastroenterol Hepatol; 2011 May; 34(5):337-45. PubMed ID: 21435744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin and the prevention of colorectal cancer.
    Ferrández A; Piazuelo E; Castells A
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An emerging role for anti-inflammatory agents for chemoprevention.
    Chan AT; Detering E
    Recent Results Cancer Res; 2013; 191():1-5. PubMed ID: 22893197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
    Dannenberg AJ; Zakim D
    Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
    Jiménez P; García A; Santander S; Piazuelo E
    Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.
    Levine AJ; Wallace K; Tsang S; Haile RW; Saibil F; Ahnen D; Cole BF; Barry EL; Munroe DJ; Ali IU; Ueland P; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2409-15. PubMed ID: 18768511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COX-2 inhibitors: cancer trials test new uses for pain drug.
    Michalowski J
    J Natl Cancer Inst; 2002 Feb; 94(4):248-9. PubMed ID: 11854385
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chemoprevention of colorectal cancer].
    Herszényi L; Juhász M; Prónai L; Tulassay Z
    Orv Hetil; 2004 Mar; 145(12):603-10. PubMed ID: 15119114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase inhibitors: drugs for cancer prevention.
    Shiff SJ; Shivaprasad P; Santini DL
    Curr Opin Pharmacol; 2003 Aug; 3(4):352-61. PubMed ID: 12901943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of colon cancer prevention.
    Umar A; Viner JL; Hawk ET
    Ann N Y Acad Sci; 2001 Dec; 952():88-108. PubMed ID: 11795446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention strategies using NSAIDs and COX-2 inhibitors.
    Keller JJ; Giardiello FM
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S140-9. PubMed ID: 14508092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin and Delayed Chemoprevention of Colorectal Cancer.
    Giovannucci E
    Clin Chem; 2018 Nov; 64(11):1668-1669. PubMed ID: 30068694
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H
    Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
    Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.
    Marin JJ; Sanchez de Medina F; Castaño B; Bujanda L; Romero MR; Martinez-Augustin O; Moral-Avila RD; Briz O
    Drug Metab Rev; 2012 May; 44(2):148-72. PubMed ID: 22497631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin as a chemoprevention agent for colorectal cancer.
    Lee CS; McNamara D; O'Morain CA
    Curr Drug Metab; 2012 Nov; 13(9):1313-22. PubMed ID: 22493984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COX-2 active agents in the chemoprevention of colorectal cancer.
    Kraus S; Naumov I; Arber N
    Recent Results Cancer Res; 2013; 191():95-103. PubMed ID: 22893201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects in NSAID-derived chemoprevention of colorectal cancer.
    Chell S; Patsos HA; Qualtrough D; H-Zadeh AM; Hicks DJ; Kaidi A; Witherden IR; Williams AC; Paraskeva C
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):667-71. PubMed ID: 16042570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.